marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Organogenesis Holdings Balance Sheet 2011-2024 | ORGO
Annual Balance Sheet Organogenesis Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-27.3 M | -72.8 M | -55.8 M | -31.8 M | 40.4 M | 20.3 M | -25.9 K | -1.04 M | 48.9 K | - | - | - | - |
Long Term Debt |
66.6 M | 20.9 M | 46.9 M | 53 M | 83.1 M | 39.1 M | - | - | - | - | - | - | - |
Long Term Debt Current |
10 M | 8.71 M | 11.8 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 105 M | 50.2 M | 10.8 M | 10.8 M | - | - | - | - | - |
Total Current Liabilities |
80.5 M | 75 M | 82.7 M | 68.2 M | 59.9 M | 66.4 M | 3.93 M | 478 K | - | - | - | - | - |
Total Liabilities |
181 M | 184 M | 202 M | 148 M | 165 M | 117 M | 14.8 M | 11.3 M | 416 K | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-41 M | -45.3 M | -60.8 M | -153 M | -171 M | -130 M | -2.33 M | -234 K | -25.2 K | - | - | - | - |
Total Assets |
460 M | 449 M | 443 M | 294 M | 221 M | 164 M | 313 M | 311 M | 416 K | - | - | - | - |
Cash and Cash Equivalents |
104 M | 102 M | 115 M | 84.8 M | 60.2 M | 21.3 M | 126 K | 1.04 M | 126 K | - | - | - | - |
Book Value |
279 M | 266 M | 241 M | 146 M | 55.6 M | 47 M | 298 M | 300 M | -162 | - | - | - | - |
Total Shareholders Equity |
279 M | 266 M | 241 M | 142 M | 55.6 M | 47 M | -15.3 M | -16 M | -162 | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Organogenesis Holdings
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
62.3 M | 63.8 M | 65.2 M | 1.89 M | 68 M | 69.4 M | 70.3 M | 41.3 M | 73.1 M | 73.1 M | 73.6 M | 46.9 M | 74.5 M | 70 M | 70 M | 70 M | 99.4 M | 99.4 M | 93.5 M | 49.6 M | 50 M | 39.7 M | 39.6 M | - | - | - | - | 52.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
168 M | 180 M | 180 M | 181 M | 186 M | 179 M | 182 M | 184 M | 201 M | 202 M | 195 M | 202 M | 181 M | 177 M | 162 M | 148 M | 148 M | 148 M | 148 M | 165 M | 165 M | 165 M | 165 M | 117 M | 117 M | 117 M | 117 M | 157 M | 14.8 M | 14.8 M | 14.8 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 416 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-47.8 M | -60.1 M | -43.1 M | -41 M | -40.4 M | -43.6 M | -48.9 M | -45.3 M | -52.8 M | -53 M | -61.7 M | -60.8 M | -112 M | -120 M | -141 M | -155 M | -155 M | -151 M | -151 M | -171 M | -171 M | -171 M | -171 M | -130 M | -130 M | -130 M | -130 M | -65.4 M | -2.33 M | -2.33 M | -2.33 M | -234 K | -234 K | -234 K | -234 K | -25.2 K | -25.2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
446 M | 443 M | 458 M | 460 M | 463 M | 450 M | 446 M | 449 M | 457 M | 456 M | 436 M | 443 M | 370 M | 356 M | 319 M | 290 M | 290 M | 294 M | 294 M | 221 M | 221 M | 221 M | 221 M | 164 M | 164 M | 164 M | 164 M | 149 M | 313 M | 313 M | 313 M | 311 M | 311 M | 311 M | 311 M | 416 K | 416 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
94.3 M | 89.9 M | 88.6 M | 104 M | 98.8 M | 89.5 M | 89.4 M | 102 M | 108 M | 113 M | 109 M | 114 M | 103 M | 90.3 M | 77.5 M | 84.8 M | 36.5 M | 84.4 M | 84.4 M | 60.2 M | 60.2 M | 60.2 M | 60.2 M | 21.3 M | 21.3 M | 21.3 M | 21.3 M | 2.31 M | 126 K | 126 K | 126 K | 1.04 M | 1.04 M | 1.04 M | 1.04 M | 126 K | 126 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
279 M | 264 M | 278 M | 279 M | 277 M | 271 M | 264 M | 266 M | 256 M | 254 M | 242 M | 241 M | 189 M | 179 M | 157 M | 142 M | 142 M | 146 M | 146 M | 55.6 M | 55.6 M | 55.6 M | 55.6 M | 47 M | 47 M | 47 M | 47 M | -8.56 M | 298 M | 298 M | 298 M | 300 M | 300 M | 300 M | 300 M | -162 | 416 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
279 M | 264 M | 278 M | 279 M | 277 M | 271 M | 264 M | 266 M | 256 M | 254 M | 242 M | 241 M | 189 M | 175 M | 153 M | 142 M | 142 M | 146 M | 146 M | 52 M | 55.6 M | 55.6 M | 55.6 M | 39.9 M | 47 M | 47 M | 47 M | -15.3 M | 5 M | 5 M | 5 M | -16 M | 5 M | 5 M | 5 M | 3.51 M | -162 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency